Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty | MicrobiomeTrials← Back to trialsNCT07775248
Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-02-11Est. Completion: 2026-10-20
Enrollment target: 150 participants Locations- Henry Ford Medical Center - Grosse Pointe Cottage, Grosse Pointe Farms, Michigan, United States
Other microbiome trials you might be interested in
Knee OsteoarthritisHip Osteoarthritis
People who live in rural areas and have hip or knee arthritis can have difficulty receiving physical therapy (PT) close …
Edmonton, CanadaEst. completion Dec 31, 2028
ACL Reconstruction
Kinesiophobia, defined as an excessive and irrational fear of physical movement due to perceived vulnerability to injury…
Caparica, PortugalEst. completion Dec 1, 2026
Recruiting
To establish the efficacy and safety of CARTISTEM®, a combination product composed of allogeneic human umbilical cord bl…
Birmingham, United StatesEst. completion Jun 30, 2029